Bio Green Med Solution (BGMS) Free Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.20 Bn | 133.34 Bn | 2.84 Bn | 9.25% |
| 2 | Regeneron Pharmaceuticals | 86.81 Bn | 78.81 Bn | 3.93 Bn | -38.10% |
| 3 | Argenx Se | 64.99 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.45 Bn | 52.31 Bn | 52.00 Mn | 38.94% |
| 5 | Revolution Medicines | 44.65 Bn | 44.65 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 96.00% |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.12 Bn | 992.69 Mn | 152.82% |
| 8 | Royalty Pharma | 28.18 Bn | 27.35 Bn | - | 31.57% |
| 9 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 58.53% |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 | 66.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.67% |
| Mar 31, 2026 | 91.41% |
| Dec 31, 2025 | 97.57% |
| Sep 30, 2025 | 85.85% |
| Jun 30, 2025 | 65.76% |
| Mar 31, 2025 | -572.26% |
| Dec 31, 2024 | 65.32% |
| Sep 30, 2024 | 24.01% |
| Jun 30, 2024 | -136.32% |
| Mar 31, 2024 | 92.97% |
| Dec 31, 2023 | 24.36% |
| Sep 30, 2023 | 42.08% |
| Jun 30, 2023 | 31.96% |
| Mar 31, 2023 | -1.30% |
| Dec 31, 2022 | -13.58% |
| Sep 30, 2022 | -12.04% |
| Jun 30, 2022 | 53.82% |
| Mar 31, 2022 | -86.03% |
| Dec 31, 2021 | -281.16% |
| Sep 30, 2021 | -185.41% |